Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

736
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
736
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

544
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
544
Drug Therapy01:28

Drug Therapy

239
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
239
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

806
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
806
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Towards the use of functional near-infrared spectroscopy as an assessment tool in disorders of consciousness.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

Detecting Awareness in the Intensive Care Unit Using Functional Near-Infrared Spectroscopy.

Annals of neurology·2025
Same author

Aortic Bioprosthetic Stenosis Leading to Heyde Syndrome.

JACC. Case reports·2025
Same author

Perspectives on Physical Activity and Learning from Children With and Without ADHD.

Sports (Basel, Switzerland)·2025
Same author

Publisher Correction: fNIRS reproducibility varies with data quality, analysis pipelines, and researcher experience.

Communications biology·2025
Same author

Assessing the consistency and sensitivity of the neural correlates of narrative stimuli using functional near-infrared spectroscopy.

Imaging neuroscience (Cambridge, Mass.)·2025

相关实验视频

Updated: Jan 13, 2026

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.6K

药物与ADHD中的运动:药物和身体活动之间的相互作用对神经认知功能的影响

Beverly-Ann Hoy1, Michelle Bi1, Matthew Lam1

  • 1Faculty of Education, Western University, London, ON N6G 1G7, Canada.

Brain sciences
|October 29, 2025
PubMed
概括

在执行功能任务期间的运动可以提高ADHD的未服用药物的儿童的大脑活动和表现,与服用药物的孩子不同. 这表明,身体活动可能有助于ADHD的注意力,当药物治疗不是一种选择时.

关键词:
治疗ADHD的药物治疗注意缺陷多动性障碍 (ADHD) 是一种注意缺陷多动性障碍.患有多动性多动症的儿童.认知和行为调制.在ADHD中皮质低兴奋.功能近红外光谱学近红外光谱学药物治疗和体力活动.身体活动干预措施

更多相关视频

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

10.9K
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

6.3K

相关实验视频

Last Updated: Jan 13, 2026

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.6K
Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

10.9K
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

6.3K

科学领域:

  • 神经科学是一个神经科学.
  • 发展心理学 发展心理学
  • 儿科 儿科 儿科

背景情况:

  • 儿科注意力缺陷/多动障碍 (ADHD) 与皮质不充分兴奋有关.
  • 运动可以在需要注意力的任务中弥补不足的兴奋.
  • 药物对运动对ADHD的影响的影响尚不清楚.

研究的目的:

  • 研究执行功能任务中的运动如何影响ADHD儿童的背侧前额叶皮层 (DLPFC) 激活和抑制控制.
  • 检查药物状态对这些影响的影响.

主要方法:

  • 26名患有多动症的儿童 (15名服用药物,11名未服用药物) 和24名对照组进行了Stroop任务.
  • 在坐着 (静止) 和踩踏桌子循环 (移动) 时完成任务.
  • 功能近红外谱学 (fNIRS) 测量了左侧DLPFC的激活.

主要成果:

  • 没有药物治疗的ADHD儿童显示左侧DLPFC活动增加,运动期间Stroop任务准确性更好.
  • 服用药物治疗的ADHD儿童没有从运动中受益;有些人显示DLPFC激活减少.
  • 对照组在运动时显示了DLPFC激活的增加,类似于未服用药物的ADHD参与者.

结论:

  • 在执行任务期间的体力活动增强了DLPFC激活和抑制控制在没有药物的ADHD儿童.
  • 服用药物治疗的ADHD儿童没有显示这些好处.
  • 运动可以作为ADHD注意力的补偿策略,当药物治疗不可行或无法容忍时.